marijuana stocks

Insys Therapeutics tops 4Q revenue forecasts

Insys Therapeutics posts 4Q revenue of $66.5 million, result beats expectations

CHANDLER, Ariz. (AP) — Insys Therapeutics Inc. (INSY) on Tuesday reported fourth-quarter net income of $9.3 million.

On a per-share basis, the Chandler, Arizona-based company said it had net income of 25 cents. Earnings, adjusted for stock option expense, were 53 cents per share.

The specialty pharmaceutical company posted revenue of $66.5 million in the period, surpassing Street forecasts. Analysts expected $64.6 million, according to Zacks.

For the year, the company reported profit of $38 million, or $1.04 per share. Revenue was reported as $222.1 million.

Insys Therapeutics shares have risen 33 percent since the beginning of the year. The stock has increased 25 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSY at https://www.zacks.com/ap/INSY

_____

Keywords: Insys Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Curaleaf Holdings, Inc. (CURLF) Expands Grassroots Premium Cannabis Brand to New Jersey

Curaleaf Expands Grassroots Premium Cannabis Brand to New Jersey Curaleaf Holdings, Inc.…

Curaleaf Holdings, Inc. (CURLF) Expands New Jersey Adult-Use Sales to Bordentown Dispensary

Curaleaf Expands New Jersey Adult-Use Sales to Bordentown Dispensary Curaleaf Holdings, Inc.…

Verano Holdings Corp. (VRNOF) Launches Round Up for Cannabis Reform Dispensary Donation Program

Verano Launches Round Up for Cannabis Reform Dispensary Donation Program Benefitting The…

$PMCM Form 8-K

Form 8-K for PRIMCO MANAGEMENT INC. 4-May-2015 Changes in Registrant’s Certifying Accountant,…